According to an annual report by My Green Lab, the biotech and pharmaceutical sectors still have some supply chain hurdles to ...

Eton has acquired the rights in the US to Amglidia for neonatal diabetes mellitus, from French biotechnology company AMMTeK.

The deal suggests Roche sees substantial promise in Poseida’s technology, as the offer is 215% above the biotech’s closing ...

Invesco Health Care Fund underperformed its benchmark. Despite earlier signs of improving trends, our health care outlook is ...

Trump’s FDA pick, Marty Makary, appears to be quelling fears about a major disruption to biotech and pharma. Neuralink ...

Zydus Lifesciences is exploring mergers, acquisitions, and licensing to bolster its specialty portfolio in the US, ...

The Company convertedfrom a Private Limited Company to a Public Limited Company and the name of the Company was changed to `Windlas Biotech Limited'. A fresh Certificate of Incorporation dated April ...

Gilead and Aelix first teamed up in 2018 for a clinical research collaboration agreement to investigate the vaccine.

Mereo BioPharma targets osteogenesis imperfecta market growth with setrusumab. Discover why MREO stock is well-positioned for ...

India presently represents 3-4% of global biosimilar production, second to China and aims to increase it significantly. With ...

Delve into the field of miRNA with 7 promising companies with miRNA-focused candidates in the pipeline, from oncology to neurodegeneration.

ONSHINDO OSAKA, a premium Japanese skincare brand, places clinical trials at the core of its mission to deliver safe and effective products. With consumers increasingly aware of what they apply to ...